Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT

OBJECTIVE: To explore the prognostic significance of the stage at which a minimal residual disease (MRD)-negative status is achieved for patients with newly diagnosed multiple myeloma (NDMM) who received autologous hematopoietic stem cell transplantation (ASCT). CASES AND METHODS: A retrospective an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qian, Li, Xiaozhe, Gu, Jingli, Huang, Beihui, Liu, Junru, Chen, Meilan, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157574/
https://www.ncbi.nlm.nih.gov/pubmed/35664799
http://dx.doi.org/10.3389/fonc.2022.776920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157574/
https://www.ncbi.nlm.nih.gov/pubmed/35664799
http://dx.doi.org/10.3389/fonc.2022.776920

Ejemplares similares